Chemotherapy with low-dose docetaxel and estramustine phosphate in patient with liver dysfunction due to liver metastases of hormone-refractory prostate cancer : a case report
A 82-year-old man was referred to our hospital for treatment of hormone-refractory prostate cancer with liver metastases. The obstruction of intrahepatic bile ducts due to the rapid growth of liver metastases induced liver dysfunction. We administered 25 mg/m(2) docetaxel on day1 and 280 mg/body est...
| Publié dans: | Hinyokika kiyo. Acta urologica Japonica. - 1962. - 56(2010), 1 vom: 31. Jan., Seite 45-8 |
|---|---|
| Auteur principal: | |
| Autres auteurs: | , , , , , , , , , , |
| Format: | Article |
| Langue: | Japanese |
| Publié: |
2010
|
| Accès à la collection: | Hinyokika kiyo. Acta urologica Japonica |
| Sujets: | Case Reports Journal Article Antineoplastic Agents Antineoplastic Agents, Alkylating Taxoids Docetaxel 15H5577CQD Estramustine 35LT29625A |
| Résumé: | A 82-year-old man was referred to our hospital for treatment of hormone-refractory prostate cancer with liver metastases. The obstruction of intrahepatic bile ducts due to the rapid growth of liver metastases induced liver dysfunction. We administered 25 mg/m(2) docetaxel on day1 and 280 mg/body estramustine phosphate on day 1 to day 3, every 4 weeks. After two courses of this combined chemothrapy, the liver metastases were markedly reduced in size with the rapid improvement of liver function |
|---|---|
| Description: | Date Completed 18.03.2010 Date Revised 01.12.2018 published: Print Citation Status MEDLINE |
| ISSN: | 0018-1994 |